ASD
The prevalence of these deleterious mutations in cases and controls indicates that they do not represent major risk factor for ASD (MTNR1A case 3.6% vs controls 4.4%; MTNR1B case 4.7% vs 3% controls).
The prevalence of these deleterious mutations in cases and controls indicates that they do not represent major risk factor for <span class="disease" id="20657642-10-127-130">ASD</span> (MTNR1A case 3.6% vs controls 4.4%; <span class="gene" id="20657642-10-167-173">MTNR1B</span> case 4.7% vs 3% controls).